Exodus Point Capital Management, LP Magenta Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$9.76 - $14.15 $188,904 - $273,873
-19,355 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.66 - $13.38 $148,259 - $258,969
19,355 New
19,355 $229,000
Q3 2020

Nov 16, 2020
SELL
$6.52 - $8.94 $285,413 - $391,348
-43,775 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$6.18 - $10.76 $270,529 - $471,019
43,775 New
43,775 $329,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email